140 related articles for article (PubMed ID: 26779615)
1. Novel players in β-thalassemia dyserythropoiesis and new therapeutic strategies.
Arlet JB; Dussiot M; Moura IC; Hermine O; Courtois G
Curr Opin Hematol; 2016 May; 23(3):181-8. PubMed ID: 26779615
[TBL] [Abstract][Full Text] [Related]
2. HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia.
Arlet JB; Ribeil JA; Guillem F; Negre O; Hazoume A; Marcion G; Beuzard Y; Dussiot M; Moura IC; Demarest S; de Beauchêne IC; Belaid-Choucair Z; Sevin M; Maciel TT; Auclair C; Leboulch P; Chretien S; Tchertanov L; Baudin-Creuza V; Seigneuric R; Fontenay M; Garrido C; Hermine O; Courtois G
Nature; 2014 Oct; 514(7521):242-6. PubMed ID: 25156257
[TBL] [Abstract][Full Text] [Related]
3. XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia.
Guillem F; Dussiot M; Colin E; Suriyun T; Arlet JB; Goudin N; Marcion G; Seigneuric R; Causse S; Gonin P; Gastou M; Deloger M; Rossignol J; Lamarque M; Choucair ZB; Gautier EF; Ducamp S; Vandekerckhove J; Moura IC; Maciel TT; Garrido C; An X; Mayeux P; Mohandas N; Courtois G; Hermine O
Haematologica; 2020 Sep; 105(9):2240-2249. PubMed ID: 33054049
[TBL] [Abstract][Full Text] [Related]
4. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.
Dussiot M; Maciel TT; Fricot A; Chartier C; Negre O; Veiga J; Grapton D; Paubelle E; Payen E; Beuzard Y; Leboulch P; Ribeil JA; Arlet JB; Coté F; Courtois G; Ginzburg YZ; Daniel TO; Chopra R; Sung V; Hermine O; Moura IC
Nat Med; 2014 Apr; 20(4):398-407. PubMed ID: 24658077
[TBL] [Abstract][Full Text] [Related]
5. EDAG mediates Hsp70 nuclear localization in erythroblasts and rescues dyserythropoiesis in myelodysplastic syndrome.
Dong XM; Zhao K; Zheng WW; Xu CW; Zhang MJ; Yin RH; Gao R; Tang LJ; Liu JF; Chen H; Zhan YQ; Yu M; Ge CH; Gao HY; Li X; Luo T; Ning HM; Yang XM; Li CY
FASEB J; 2020 Jun; 34(6):8416-8427. PubMed ID: 32350948
[TBL] [Abstract][Full Text] [Related]
6. Ineffective erythropoiesis in β -thalassemia.
Ribeil JA; Arlet JB; Dussiot M; Moura IC; Courtois G; Hermine O
ScientificWorldJournal; 2013; 2013():394295. PubMed ID: 23606813
[TBL] [Abstract][Full Text] [Related]
7. Exogenous iron increases hemoglobin in beta-thalassemic mice.
Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
[TBL] [Abstract][Full Text] [Related]
8. Protein-based therapeutic for anemia caused by dyserythropoiesis.
Arlet JB; Guillem F; Lamarque M; Dussiot M; Maciel T; Moura I; Hermine O; Courtois G
Expert Rev Proteomics; 2016 Nov; 13(11):983-992. PubMed ID: 27661264
[TBL] [Abstract][Full Text] [Related]
9. Association of the Degree of Erythroid Expansion and Maturation Arrest with the Clinical Severity of β0-Thalassemia/Hemoglobin E Patients.
Suriyun T; Kaewsakulthong W; Khamphikham P; Chumchuen S; Hongeng S; Fucharoen S; Sripichai O
Acta Haematol; 2021; 144(6):660-671. PubMed ID: 34535581
[TBL] [Abstract][Full Text] [Related]
10. Dyserythropoiesis in iron deficiency and in beta-thalassemia.
Zago MA; Costa FF; Bottura C
Braz J Med Biol Res; 1984; 17(2):135-42. PubMed ID: 6518337
[TBL] [Abstract][Full Text] [Related]
11. The Roles of Mitophagy and Autophagy in Ineffective Erythropoiesis in β-Thalassemia.
Chaichompoo P; Svasti S; Smith DR
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142738
[TBL] [Abstract][Full Text] [Related]
12. Integrative proteome and transcriptome analysis of extramedullary erythropoiesis and its reversal by transferrin treatment in a mouse model of beta-thalassemia.
Vallelian F; Gelderman-Fuhrmann MP; Schaer CA; Puglia M; Opitz L; Baek JH; Vostal J; Buehler PW; Schaer DJ
J Proteome Res; 2015 Feb; 14(2):1089-100. PubMed ID: 25566950
[TBL] [Abstract][Full Text] [Related]
13. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
[TBL] [Abstract][Full Text] [Related]
14. [HSP70, an erythropoiesis regulator that determines the fate of erythroblasts between death and differentiation].
Hermine O; Arlet JB; Ribeil JA; Guillerm F; Vandekerkhove J; Courtois G
Transfus Clin Biol; 2013 May; 20(2):144-7. PubMed ID: 23643330
[TBL] [Abstract][Full Text] [Related]
15. Increased autophagy leads to decreased apoptosis during β-thalassaemic mouse and patient erythropoiesis.
Chaichompoo P; Nithipongvanitch R; Kheansaard W; Tubsuwan A; Srinoun K; Vadolas J; Fucharoen S; Smith DR; Winichagoon P; Svasti S
Sci Rep; 2022 Nov; 12(1):18628. PubMed ID: 36329049
[TBL] [Abstract][Full Text] [Related]
16. A synthetic model of human beta-thalassemia erythropoiesis using CD34+ cells from healthy adult donors.
Lee YT; Kim KS; Byrnes C; de Vasconcellos JF; Noh SJ; Rabel A; Meier ER; Miller JL
PLoS One; 2013; 8(7):e68307. PubMed ID: 23861885
[TBL] [Abstract][Full Text] [Related]
17. Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes.
Frisan E; Vandekerckhove J; de Thonel A; Pierre-Eugène C; Sternberg A; Arlet JB; Floquet C; Gyan E; Kosmider O; Dreyfus F; Gabet AS; Courtois G; Vyas P; Ribeil JA; Zermati Y; Lacombe C; Mayeux P; Solary E; Garrido C; Hermine O; Fontenay M
Blood; 2012 Feb; 119(6):1532-42. PubMed ID: 22160620
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of beta thalassemia--a guide to molecular therapies.
Thein SL
Hematology Am Soc Hematol Educ Program; 2005; ():31-7. PubMed ID: 16304356
[TBL] [Abstract][Full Text] [Related]
19. Enhanced activation of autophagy in β-thalassemia/Hb E erythroblasts during erythropoiesis.
Lithanatudom P; Wannatung T; Leecharoenkiat A; Svasti S; Fucharoen S; Smith DR
Ann Hematol; 2011 Jul; 90(7):747-58. PubMed ID: 21221583
[TBL] [Abstract][Full Text] [Related]
20. The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model.
Matte A; Federti E; Kung C; Kosinski PA; Narayanaswamy R; Russo R; Federico G; Carlomagno F; Desbats MA; Salviati L; Leboeuf C; Valenti MT; Turrini F; Janin A; Yu S; Beneduce E; Ronseaux S; Iatcenko I; Dang L; Ganz T; Jung CL; Iolascon A; Brugnara C; De Franceschi L
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33822774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
